These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8857560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis.
    Willey ML, de Denus S, Spinler SA.
    Pharmacotherapy; 2002 Apr; 22(4):492-9. PubMed ID: 11939684
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hirudin in renal insufficiency.
    Fischer KG.
    Semin Thromb Hemost; 2002 Oct; 28(5):467-82. PubMed ID: 12420243
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
    Iyer L, Koza M, Iqbal O, Calabria R, Fareed J.
    Thromb Res; 1993 Feb 01; 69(3):259-69. PubMed ID: 8475476
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R, Camez A, Veys N, Van Loo A, Dhondt AM, Ringoir S.
    Thromb Haemost; 1997 Apr 01; 77(4):650-5. PubMed ID: 9134637
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systems.
    Koster A, Merkle F, Hansen R, Loebe M, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F.
    Anesth Analg; 2000 Aug 01; 91(2):265-9. PubMed ID: 10910829
    [Abstract] [Full Text] [Related]

  • 16. The direct thrombin inhibitor hirudin.
    Greinacher A, Warkentin TE.
    Thromb Haemost; 2008 May 01; 99(5):819-29. PubMed ID: 18449411
    [Abstract] [Full Text] [Related]

  • 17. Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393).
    Thürmann P, Harder S, Kirchmaier CM.
    Eur J Clin Pharmacol; 1995 May 01; 48(3-4):241-6. PubMed ID: 7589048
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. I. Assay characteristics and quantitation of recombinant hirudin.
    Lackmann M, Hoad R, Kakakios A, Geczy CL.
    Thromb Res; 1991 Sep 15; 63(6):595-607. PubMed ID: 1780804
    [Abstract] [Full Text] [Related]

  • 19. Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.
    Choi TS, Khan AI, Greilich PE, Kroll MH.
    Am J Clin Pathol; 2006 Feb 15; 125(2):290-5. PubMed ID: 16393689
    [Abstract] [Full Text] [Related]

  • 20. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
    Fischer KG, van de Loo A, Böhler J.
    Kidney Int Suppl; 1999 Nov 15; (72):S46-50. PubMed ID: 10560805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.